At Boomerang Biopathways, we specialize in facilitating and accelerating clinical trials in Australia for BioPharma and MedTech companies worldwide. Time and capital are critical in maximizing value creation, and our mission is to enhance your clinical outcomes swiftly and cost-effectively.
Why Australia?
Cost Advantage: Reduce your clinical trial costs by up to 67% compared to the U.S.* Australia’s R&D Tax Incentive scheme also offers up to 43.5% cashback on trial expenses.
Faster Timelines: Leverage streamlined regulatory and ethics approval processes to initiate clinical trials in as little as 3-4 months.
High-Quality Data: Generate robust data recognized by international regulatory bodies like the FDA and frequently published in peer-reviewed journals.
We offer a full-service, hands-on approach to manage your entire clinical trial process:
Preparation and Scoping: Develop your business case and clinical strategy with our seasoned experts.
Corporate/Legal Setup: Establish your Australian subsidiary efficiently, navigating local legal frameworks with ease.
Clinical Trial Execution: Access our extensive network to select top-tier CROs, identify patient populations, and manage regulatory requirements seamlessly.
Our leadership comprises industry veterans with extensive experience in global regulatory approvals and clinical trials. We provide 24/7 white-glove service, ensuring personalized support and hands-on management at every stage.
Partner with Boomerang Biopathways
Maximize value creation and accelerate your clinical development by partnering with Boomerang Biopathways. Let us navigate the Australian landscape for you, reducing costs and achieving superior outcomes.
Contact us today to learn how we can accelerate your path to success.
*Based on internal analysis comparing average clinical trial costs in Australia and the U.S.